147 related articles for article (PubMed ID: 19010442)
1. TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival.
Lambert E; Bridoux L; Devy J; Dassé E; Sowa ML; Duca L; Hornebeck W; Martiny L; Petitfrère-Charpentier E
Int J Biochem Cell Biol; 2009 May; 41(5):1102-15. PubMed ID: 19010442
[TBL] [Abstract][Full Text] [Related]
2. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
3. Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression.
Hornebeck W; Lambert E; Petitfrère E; Bernard P
Biochimie; 2005; 87(3-4):377-83. PubMed ID: 15781325
[TBL] [Abstract][Full Text] [Related]
4. Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities.
Djafarzadeh R; Mojaat A; Vicente AB; von Lüttichau I; Nelson PJ
Biol Chem; 2004 Jul; 385(7):655-63. PubMed ID: 15318815
[TBL] [Abstract][Full Text] [Related]
5. Latent MMP-9 is bound to TIMP-1 before secretion.
Roderfeld M; Graf J; Giese B; Salguero-Palacios R; Tschuschner A; Müller-Newen G; Roeb E
Biol Chem; 2007 Nov; 388(11):1227-34. PubMed ID: 17976016
[TBL] [Abstract][Full Text] [Related]
6. A crucial role for Lyn in TIMP-1 erythroid cell survival signalling pathway.
Bridoux L; Etique N; Lambert E; Thevenard J; Sowa ML; Belloy N; Dauchez M; Martiny L; Charpentier E
FEBS Lett; 2013 May; 587(10):1524-8. PubMed ID: 23583449
[TBL] [Abstract][Full Text] [Related]
7. GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing.
Djafarzadeh R; Noessner E; Engelmann H; Schendel DJ; Notohamiprodjo M; von Luettichau I; Nelson PJ
Oncogene; 2006 Mar; 25(10):1496-508. PubMed ID: 16261161
[TBL] [Abstract][Full Text] [Related]
8. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.
Ardi VC; Van den Steen PE; Opdenakker G; Schweighofer B; Deryugina EI; Quigley JP
J Biol Chem; 2009 Sep; 284(38):25854-66. PubMed ID: 19608737
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.
Ries C; Pitsch T; Mentele R; Zahler S; Egea V; Nagase H; Jochum M
Biochem J; 2007 Aug; 405(3):547-58. PubMed ID: 17489740
[TBL] [Abstract][Full Text] [Related]
11. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment.
Hernández-Guillamon M; Delgado P; Ortega L; Pares M; Rosell A; García-Bonilla L; Fernández-Cadenas I; Borrell-Pagès M; Boada M; Montaner J
J Neurosci Res; 2009 Jul; 87(9):2115-25. PubMed ID: 19235898
[TBL] [Abstract][Full Text] [Related]
12. Changes in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus.
Matthews FJ; Cook SD; Majid MA; Dick AD; Smith VA
Exp Eye Res; 2007 Jun; 84(6):1125-34. PubMed ID: 17449031
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression during cardiac neural crest cell migration and its role in proMMP-2 activation.
Cantemir V; Cai DH; Reedy MV; Brauer PR
Dev Dyn; 2004 Dec; 231(4):709-19. PubMed ID: 15497141
[TBL] [Abstract][Full Text] [Related]
14. Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).
Xu X; Mikhailova M; Chen Z; Pal S; Robichaud TK; Lafer EM; Baber S; Steffensen B
Matrix Biol; 2011 Sep; 30(7-8):404-12. PubMed ID: 21839835
[TBL] [Abstract][Full Text] [Related]
15. The effects of Candida proteinases on human proMMP-9, TIMP-1 and TIMP-2.
Pärnänen P; Meurman JH; Sorsa T
Mycoses; 2011 Jul; 54(4):325-30. PubMed ID: 20406392
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival.
Lambert E; Boudot C; Kadri Z; Soula-Rothhut M; Sowa ML; Mayeux P; Hornebeck W; Haye B; Petitfrere E
Biochem J; 2003 Jun; 372(Pt 3):767-74. PubMed ID: 12639219
[TBL] [Abstract][Full Text] [Related]
17. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.
Ardi VC; Kupriyanova TA; Deryugina EI; Quigley JP
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20262-7. PubMed ID: 18077379
[TBL] [Abstract][Full Text] [Related]
18. Cell-based evidence for aminopeptidase N/CD13 inhibitor actinonin targeting of MT1-MMP-mediated proMMP-2 activation.
Sina A; Lord-Dufour S; Annabi B
Cancer Lett; 2009 Jul; 279(2):171-6. PubMed ID: 19264392
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat.
Pham Van T; Couchie D; Martin-Garcia N; Laperche Y; Zafrani ES; Mavier P
Matrix Biol; 2008 Oct; 27(8):674-81. PubMed ID: 18678246
[TBL] [Abstract][Full Text] [Related]
20. The expression of human corneal MMP-2, MMP-9, proMMP-13 and TIMP-1 in bullous keratopathy and keratoconus.
Predović J; Balog T; Marotti T; Gabrić N; Bohac M; Romac I; Dekaris I
Coll Antropol; 2008 Oct; 32 Suppl 2():15-9. PubMed ID: 19138000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
